DUSP6 (Dual Specificity Phosphatase 6), also known as MKP3 (Mitogen-Activated Protein Kinase Phosphatase 3), is a dual-specificity protein phosphatase that specifically dephosphorylates and inactivates ERK1/2 (Extracellular Signal-Regulated Kinases 1 and 2). As a negative regulator of the RAS-RAF-MEK-ERK MAPK pathway, DUSP6 plays critical roles in signal termination, cellular homeostasis, and tissue-specific functions. [1]
| DUSP6/MKP3 Protein | |
|---|---|
| Protein Name | Dual Specificity Phosphatase 6 (MKP3) |
| Gene Symbol | DUSP6 |
| Gene | [DUSP6 Gene](/genes/dusp6) |
| UniProt ID | [O43508](https://www.uniprot.org/uniprot/O43508) |
| Protein Family | DUSP family, MAP kinase phosphatases |
| Molecular Weight | 39.8 kDa (400 aa) |
| Subcellular Location | Cytoplasm, nucleus |
| Tissue Expression | Ubiquitous; high in brain, lung, pancreas |
DUSP6 belongs to the dual-specificity phosphatase (DUSP) family and contains characteristic structural features: [2]
| Region | Position | Function |
|---|---|---|
| N-terminal non-catalytic domain | 1-185 aa | Docking motif (D-domain) for MAPK binding; determines substrate specificity |
| Phosphatase domain | 186-400 aa | Catalytic domain with active site HCX5R motif |
| C-terminal tail | 370-400 aa | Regulatory sequences |
The catalytic domain contains the active site signature motif HCX5R (His-Cys-X5-Arg), where Cys187 serves as the nucleophilic residue that attacks the phosphotyrosine or phosphothreonine/serine substrate. DUSP6 shows high specificity for ERK1/2 compared to JNK or p38 MAPKs.
DUSP6 functions as a feedback regulator of the MAPK/ERK pathway: [1:1]
Active ERK1/2 → Transcription factors → Gene expression → DUSP6 transcription → DUSP6 protein → ERK1/2 dephosphorylation → Signal termination
This creates a negative feedback loop that ensures transient MAPK activation and prevents excessive or prolonged signaling.
In the central nervous system, DUSP6 plays important roles: [3]
DUSP6/MKP3 has emerged as a significant player in Parkinson's disease pathogenesis: [4]
DUSP6 dysregulation contributes to PD through multiple mechanisms:
MAPK dysregulation is well-documented in AD: [5] [6]
DUSP6 interacts with and regulates multiple cellular proteins:
| Interactor | Interaction Type | Functional Relevance |
|---|---|---|
| ERK1/2 | Direct binding/dephosphorylation | Primary substrate |
| MEK1/2 | Feedback regulation | Upstream regulator |
| JNK/p38 | Secondary substrate | Broader MAPK regulation |
| 14-3-3 proteins | Binding | Subcellular localization |
| Hsp90 | Chaperone interaction | Protein stability |
| MKP1/MKP5 | Cross-regulation | DUSP family interactions |
Targeting DUSP6/MAPK dysregulation represents a promising therapeutic approach: [6:1]
DUSP6/MKP3 is a dual-specificity phosphatase that negatively regulates MAPK/ERK signaling by dephosphorylating ERK1/2. In neurodegenerative diseases, DUSP6 dysregulation contributes to aberrant MAPK activation in affected neurons. In Parkinson's disease specifically, reduced DUSP6 expression in the substantia nigra may contribute to dopaminergic neuron loss through sustained ERK activation. Understanding DUSP6 function provides insight into therapeutic strategies targeting MAPK dysregulation in AD, PD, and related disorders.
Kidambi S, Yarmus J, Malhotra R. DUSP6/MKP3: a key regulator of ERK activity in development and disease. J Dev Biol. 2019. ↩︎ ↩︎
Farooq A, Zhou MM. Structure and regulation of MAPK phosphatases. Cell Signal. 2006. ↩︎
Ma'ayan A, Jenkins SL, Gold S, et al. DUSP6 in neural development and disease: emerging roles and mechanisms. Neural Plast. 2018. ↩︎
Chu C, Zhang Y, Ding Q, et al. ERK phosphorylation and dopaminergic neuron survival in Parkinson's disease. J Mol Neurosci. 2020. ↩︎
Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta Mol Basis Dis. 2020. ↩︎
Shi Y, Wang J, Li W, et al. MAPK phosphatases as neuroprotective targets in neurodegenerative disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2017. ↩︎ ↩︎